サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1401785

異常ヘモグロビン症（血色素異常症）市場：タイプ別、治療薬別、流通チャネル別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023-2030年

Hemoglobinopathies Market, By Type, By Therapy, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 298 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
異常ヘモグロビン症（血色素異常症）市場：タイプ別、治療薬別、流通チャネル別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023-2030年
出版日: 2023年12月29日
発行: AnalystView Market Insights
ページ情報: 英文 298 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

異常ヘモグロビン症（血色素異常症）の市場規模は2022年に84億2,800万米ドルとなり、2023年から2030年にかけてCAGR 12.5％で拡大すると予想されます。

異常ヘモグロビン症市場- 市場力学

新興国および低所得国における異常ヘモグロビン症の蔓延が市場成長を後押し

鎌状赤血球症やサラセミアを含む異常ヘモグロビン症は、予防可能な遺伝性疾患です。鎌状赤血球症やサラセミアなどの異常ヘモグロビン症は、予防が可能な遺伝性疾患ですが、重症化すると、慢性的で生命を脅かし、死亡や身体障害につながる重大な健康リスクを伴う疾患となります。残念ながら、知識、包括的なプログラム、組織的な予防措置が不足しているため、世界中でかなりの割合の子供たちがこのような状態で生まれ、苦しんでいます。BGI Genomics Global 2023によると、世界の5.2％の人々がヘモグロビン異常を持っており、そのために毎年30万人から40万人の赤ちゃんが重度の異常ヘモグロビン症を持って生まれてきます。さらに、出生1万人のうち4.4人がサラセミアに罹患しています。サラセミアは遺伝性の異常ヘモグロビン症で、地中海沿岸地域、アフリカ、中東、東南アジア、中国南部に多いです。サラセミア症例のおよそ80％は低・中所得国で発生しており、医療へのアクセスが不均等であるため、患者の生活の質が危険にさらされる可能性が高いです。

異常ヘモグロビン症市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2023-2030年）に約12.5%のCAGRで毎年成長すると予測されています。

タイプセグメンテーションによると、鎌状赤血球症分野が予測期間中に市場を独占すると予測されます。

地域別では、北米が予測期間中に市場を独占する見込みです。

異常ヘモグロビン症市場-セグメンテーション分析：

異常ヘモグロビン症の世界市場は、タイプ、治療薬、流通チャネル、地域に基づいてセグメント化されます。

タイプに基づき、世界市場は鎌状赤血球症、サラセミア、その他に分類されます。予測期間中、鎌状赤血球症分野が市場を独占すると予想されます。

治療薬に基づき、世界の異常ヘモグロビン症産業はACE阻害剤、モノクローナル抗体薬、ヒドロキシ尿素、その他に分けられます。

流通チャネルに基づくと、市場はオンラインプロバイダー、病院薬局、ドラッグストア、小売薬局に二分されます。

異常ヘモグロビン症市場-地理的洞察

異常ヘモグロビン症市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。北米が予測期間中に市場を独占すると予想されるのは、医療施設が充実してきたことと、ヘモグロビン血症に対する個人の意識が高まってきたからです。さまざまな団体が意識を高めるためにさまざまな活動を行っています。

目次

第1章 異常ヘモグロビン症市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 異常ヘモグロビン症の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 異常ヘモグロビン症産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 異常ヘモグロビン症市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 異常ヘモグロビン症市場情勢

  • ヘモグロビン症市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 異常ヘモグロビン症市場：タイプ別

  • 概要
    • タイプ別のセグメントシェア分析
    • 鎌状赤血球症
    • サラセミア
    • その他

第8章 異常ヘモグロビン症市場：治療薬別

  • 概要
    • 治療薬別のセグメントシェア分析
    • ACE阻害剤
    • モノクローナル抗体薬
    • ヒドロキシ尿素
    • その他

第9章 異常ヘモグロビン症市場：流通チャネル別

  • 概要
    • 流通チャネル別のセグメントシェア分析
    • オンラインプロバイダー
    • 病院薬局
    • ドラッグストア
    • 小売薬局

第10章 異常ヘモグロビン症市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東とアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：異常ヘモグロビン症業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Novartis AG
    • Celgene Corporation
    • bluebird bio, Inc.
    • Emmaus Life Sciences Inc.
    • Pfizer, Inc.
    • Sangamo Therapeutics, Inc.
    • Prolong Pharmaceuticals, LLC
    • Global Blood Therapeutics, Inc.
    • Gamida Cell
    • Bioverativ Inc.

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Hemoglobinopathies Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Hemoglobinopathies Market, by Type 2018-2030 (USD Million)
  • TABLE Hemoglobinopathies Market: Therapy Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy
  • TABLE Global Hemoglobinopathies Market, by Therapy 2018-2030 (USD Million)
  • TABLE Hemoglobinopathies Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Hemoglobinopathies Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Hemoglobinopathies Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Hemoglobinopathies Market, by Region 2018-2030 (USD Million)
  • TABLE North America Hemoglobinopathies Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Hemoglobinopathies Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Hemoglobinopathies Market, by Therapy, 2018-2030 (USD Million)
  • TABLE North America Hemoglobinopathies Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Hemoglobinopathies Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Hemoglobinopathies Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Hemoglobinopathies Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Europe Hemoglobinopathies Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hemoglobinopathies Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hemoglobinopathies Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hemoglobinopathies Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hemoglobinopathies Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Hemoglobinopathies Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Hemoglobinopathies Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Hemoglobinopathies Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Latin America Hemoglobinopathies Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hemoglobinopathies Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hemoglobinopathies Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hemoglobinopathies Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hemoglobinopathies Market, by Distribution Channel, 2018-2030 (USD Million)

List of Figures

  • FIGURE Hemoglobinopathies Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Therapy segment market share analysis, 2022 & 2030
  • FIGURE Therapy segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2022 & 2030
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Hemoglobinopathies Market share and leading players, 2022
  • FIGURE Europe Hemoglobinopathies Market share and leading players, 2022
  • FIGURE Asia Pacific Hemoglobinopathies Market share and leading players, 2022
  • FIGURE Latin America Hemoglobinopathies Market share and leading players, 2022
  • FIGURE Middle East and Africa Hemoglobinopathies Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Hemoglobinopathies Market share analysis by country, 2022
  • FIGURE Germany Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Hemoglobinopathies Market share analysis by country, 2022
  • FIGURE India Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Hemoglobinopathies Market share analysis by country, 2022
  • FIGURE Brazil Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Hemoglobinopathies Market share analysis by country, 2022
  • FIGURE Saudi Arabia Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Hemoglobinopathies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1986

REPORT HIGHLIGHT

Hemoglobinopathies Market size was valued at USD 8,428 Million in 2022, expanding at a CAGR of 12.5% from 2023 to 2030.

Hemoglobinopathy diagnosis and treatment are becoming more and more common due to the growing demand for newborn screening programs and the diagnosis of prenatal hemoglobin abnormalities. This is particularly critical in poorer countries where screening and awareness initiatives are only getting underway. Additionally, it is anticipated that growing patient and healthcare professional awareness of the need for early diagnosis and treatment will propel market revenue growth. This is particularly true in the case of sickle cell anemia when early detection and treatment can significantly improve patient outcomes and reduce healthcare costs. However, a significant factor that can limit market revenue development is the high cost of treatment, particularly for gene therapy and stem cell transplants. Moreover, severe legislative limitations, and a lack of access to healthcare in developing countries, especially for those in need of specialized treatment, are increasing the prevalence of hemoglobinopathies worldwide.

Hemoglobinopathies Market- Market Dynamics

Increasing prevalence of hemoglobinopathies in developing and low-income countries boosting the market growth

Haemoglobinopathies, including sickle cell disease and Thalassemia, are hereditary conditions that can be prevented. In their severe forms, they are linked to chronic, life-threatening, and life-impairing diseases with substantial health risks that can result in death or disability. Unfortunately, due to a lack of knowledge, comprehensive programs, and organized preventative measures, a significant percentage of children worldwide are born with and suffer from these conditions. According to BGI Genomics Global 2023, 5.2% of people worldwide have hemoglobin abnormalities, which causes 300,000 to 400,000 babies to be born with severe hemoglobinopathies every year. In addition, 4.4 out of every 10,000 live births is affected with thalassemia, a hereditary hemoglobinopathy that is most common in Mediterranean coastal regions, Africa, the Middle East, Southeast Asia, and southern China. Roughly 80% of cases of thalassemia take place in low- and middle-income nations, where patients' quality of life is more likely to be in danger due to unequal access to medical care. Programs to control thalassemia must include genetic counselling, screening, public awareness, and prenatal diagnosis. Considering the magnitude of the problem and the cost implications of management, suitable control measures need to be undertaken immediately.

Hemoglobinopathies Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.5% over the forecast period (2023-2030)

Based on type segmentation, the Sickle Cell Disease segment is expected to dominate the market over the forecast period

Based on region, North America is expected to dominate the market during the forecast period

Hemoglobinopathies Market- Segmentation Analysis:

The Global Hemoglobinopathies Market is segmented based on Type, Therapy, Distribution Channel, and Region.

Based on the type, the global market is categorized into Sickle Cell Disease, Thalassemia and Others. The Sickle Cell Disease segment is expected to dominate the market over the forecast period. The market for sickle cell disease diagnostics has seen several notable developments recently. The creation and uptake of novel diagnostic technology is one such trend. Modern genetic testing techniques, including next-generation sequencing and molecular diagnostics, have made it possible to identify sickle cell disease and its variations more precisely and effectively. Rapid diagnostic kits and point-of-care testing (POCT) equipment have also been developed, making screening quick and easy in a variety of healthcare settings. For instance, Molbio Diagnostics and ShanMukha Innovations partnered in May 2023 to create, develop, and market affordable point-of-care diagnostic tools for the diagnosis of disorders associated with hemoglobinopathy.

Based on the therapy, the global hemoglobinopathies industry is divided into ACE inhibitors, Monoclonal Antibody Medication, Hydroxyurea and Others.

Based on the distribution channel, the market is bifurcated into Online Providers, Hospital Pharmacy, Drug Stores and Retail Pharmacy.

Hemoglobinopathies Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period because healthcare facilities are getting better and individuals are becoming more aware of hemoglobinopathies. Different groups run different activities to raise awareness. For instance, the United States national group SCDAA advocates for people with sickle cell disease and their families by raising awareness and providing support. To foster greater awareness and enhance the lives of individuals who suffer from the disease, they arrange events, offer resources, and give instructional materials. The region's market is expected to rise as a result of several programs launched by government agencies and research institutions to support the development of new treatments for hemoglobinopathies.

Hemoglobinopathies Market- Competitive Landscape:

To increase their market share, business leaders are launching several efforts, including partnerships, collaborations, mergers and acquisitions, and intensive R&D. The key players operating in the market are Novartis AG, Celgene Corporation, bluebird bio, Inc., Emmaus Life Sciences Inc., Pfizer, Inc., Sangamo Therapeutics, Inc., Prolong Pharmaceuticals, LLC, Global Blood Therapeutics, Inc., Gamida Cell and Bioverativ Inc.

Recent Developments:

In August 2023, the FDA in the United States released the clinical hold on the Investigational New Drug (IND) application for FTX-6058, which could be used to treat sickle-cell disease (SCD). Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company that prioritizes improving the lives of patients with genetically defined rare diseases.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMOGLOBINOPATHIES MARKET KEY PLAYERS

  • Novartis AG
  • Celgene Corporation
  • bluebird bio, Inc.
  • Emmaus Life Sciences Inc.
  • Pfizer, Inc.
  • Sangamo Therapeutics, Inc.
  • Prolong Pharmaceuticals, LLC
  • Global Blood Therapeutics, Inc.
  • Gamida Cell
  • Bioverativ Inc.

GLOBAL HEMOGLOBINOPATHIES MARKET, BY TYPE

  • Sickle Cell Disease
  • Thalassemia
  • Others

GLOBAL HEMOGLOBINOPATHIES MARKET, BY THERAPY

  • ACE inhibitors
  • Monoclonal Antibody Medication
  • Hydroxyurea
  • Others

GLOBAL HEMOGLOBINOPATHIES MARKET, BY DISTRIBUTION CHANNEL

  • Online Providers
  • Hospital Pharmacy
  • Drug Stores
  • Retail Pharmacy

GLOBAL HEMOGLOBINOPATHIES MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hemoglobinopathies Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hemoglobinopathies Market Snippet by Type
    • 2.1.2. Hemoglobinopathies Market Snippet by Therapy
    • 2.1.3. Hemoglobinopathies Market Snippet by Distribution Channel
    • 2.1.4. Hemoglobinopathies Market Snippet by Country
    • 2.1.5. Hemoglobinopathies Market Snippet by Region
  • 2.2. Competitive Insights

3. Hemoglobinopathies Key Market Trends

  • 3.1. Hemoglobinopathies Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hemoglobinopathies Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hemoglobinopathies Market Opportunities
  • 3.4. Hemoglobinopathies Market Future Trends

4. Hemoglobinopathies Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hemoglobinopathies Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hemoglobinopathies Market Landscape

  • 6.1. Hemoglobinopathies Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hemoglobinopathies Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Sickle Cell Disease
    • 7.1.3. Thalassemia
    • 7.1.4. Others

8. Hemoglobinopathies Market - By Therapy

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapy, 2022 & 2030 (%)
    • 8.1.2. ACE inhibitors
    • 8.1.3. Monoclonal Antibody Medication
    • 8.1.4. Hydroxyurea
    • 8.1.5. Others

9. Hemoglobinopathies Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
    • 9.1.2. Online Providers
    • 9.1.3. Hospital Pharmacy
    • 9.1.4. Drug Stores
    • 9.1.5. Retail Pharmacy

10. Hemoglobinopathies Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Hemoglobinopathies Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Hemoglobinopathies Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Hemoglobinopathies Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Hemoglobinopathies Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Hemoglobinopathies Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Hemoglobinopathies Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Novartis AG
    • 11.2.2. Celgene Corporation
    • 11.2.3. bluebird bio, Inc.
    • 11.2.4. Emmaus Life Sciences Inc.
    • 11.2.5. Pfizer, Inc.
    • 11.2.6. Sangamo Therapeutics, Inc.
    • 11.2.7. Prolong Pharmaceuticals, LLC
    • 11.2.8. Global Blood Therapeutics, Inc.
    • 11.2.9. Gamida Cell
    • 11.2.10. Bioverativ Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us